enGene has named Theresa Podrebarac, MD, chief medical officer. Dr. Pedrebarac joins enGene from AbbVie where she served as vice president, immunology clinical development. Previously, she was vice president of early clinical development and immunology at Biogen. Prior to Biogen, she served as vice president and head of rheumatology global clinical development at EMD Serono.
Oligo Medic has appointed Jerett Creed as CEO. Most recently Mr. Creed was in charge of launching Oligo’s JointRep product in Latin America. Prior to that role, he was founder and CEO of Cardigant Medical. He previously served as interim chief financial officer for a publicly traded oil and gas company. He began his career at Johnson and Johnson, initially focused on manufacturing and product development of early angioplasty balloons and bare metal stents.